Latest Investments News

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Wesfarmers updates details on its 2025 special dividend, confirming a fully franked payout of 40 cents per share with multiple currency payment options. The dividend is part of a broader capital management initiative approved at the recent AGM.

Clean TeQ Water has raised A$6 million through a placement supported by major shareholders to fund its expanding international water and resource recovery projects while strengthening its balance sheet.

PMET Resources reports a positive feasibility study for its flagship Shaakichiuwaanaan lithium project, revealing a maiden mineral reserve and advancing environmental and exploration milestones.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

TT Investments has launched an unconditional $0.31 per security takeover bid for 360 Capital Group, aiming to delist the company from the ASX. The Independent Board Committee recommends acceptance amid significant premiums and looming governance changes.

Regal Asian Investments Limited has announced an on-market buy-back of its ordinary shares, set to run from November 2025 through November 2026, signaling a strategic move to manage its capital structure.

DigitalX Limited has increased its Bitcoin exposure to 504 BTC and invested nearly A$5 million into a yield-focused fund, navigating October's volatile crypto markets with a balanced strategy.

Metal Bank Limited has successfully closed a $2.42 million entitlement offer, bolstering its capacity to advance gold projects in Western Australia and critical minerals exploration in Queensland.

Piche Resources has successfully raised approximately AUD 2 million through an oversubscribed placement, attracting strong institutional interest and issuing free attaching options to support its Argentine exploration projects.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Block, Inc. reported a modest 2% revenue increase in Q3 2025 driven by growth in its Cash App and Square segments, alongside a $461.5 million net income. The company issued $2.2 billion in senior notes and repurchased $1.5 billion in stock, while navigating ongoing regulatory scrutiny and legal challenges.